Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Class A Common Stock, $0.001 par value per share
-
Shares outstanding
-
30,273,764
-
Total 13F shares
-
29,575,131
-
Share change
-
+12,033,429
-
Total reported value
-
$337,955,086
-
Put/Call ratio
-
137%
-
Price per share
-
$11.43
-
Number of holders
-
79
-
Value change
-
+$137,435,356
-
Number of buys
-
57
-
Number of sells
-
19
Institutional Holders of Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) as of Q4 2025
As of 31 Dec 2025,
Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,575,131 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., JOHNSON & JOHNSON, FRANKLIN RESOURCES INC, Balyasny Asset Management L.P., PERCEPTIVE ADVISORS LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, and MILLENNIUM MANAGEMENT LLC.
This page lists
79
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.